All Stories

  1. Antimicrobial Stewardship in oral and maxillofacial surgery: melting the iceberg
  2. Hoisted by Their Own Petard: Defeating Immunity Protein–Mediated Bacteriocin Resistance
  3. Correction: Scharf et al. Oxford Nanopore Technology-Based Identification of an Acanthamoeba castellanii Endosymbiosis in Microbial Keratitis. Microorganisms 2024, 12, 2292
  4. Oxford Nanopore Technology-Based Identification of an Acanthamoeba castellanii Endosymbiosis in Microbial Keratitis
  5. Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO): an international, open-label, parallel-group, randomised, controlled, non-inferiority trial
  6. Infectious Complications in Patients with Myelodysplastic Syndromes: A Report from the Düsseldorf MDS Registry
  7. Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions
  8. Disseminated Cryptococcosis Is a Common Finding among Human Immunodeficiency Virus-Infected Patients with Suspected Sepsis and Is Associated with Higher Mortality Rates
  9. Teicoplanin-Resistant Coagulase-Negative Staphylococci: Do the Current Susceptibility Testing Methods Reliably Detect This Elusive Phenotype?
  10. Cytokine Hyperresponsiveness in Children With ETV6::RUNX1-positive Acute Lymphoblastic Leukemia After Challenge With Common Pathogens
  11. Diagnostik und Therapie organischer intraorbitaler Fremdkörper
  12. Mycoplasma pneumoniae beyond the COVID-19 pandemic: where is it?
  13. Implementation of a Clostridioides difficile sentinel surveillance system in Germany: First insights for 2019–2021
  14. Spectrum and resistance in bacterial infections of the ocular surface in a German tertiary referral center 2009–2019
  15. Mycoplasma pneumoniae detections before and during the COVID-19 pandemic: results of a global survey, 2017 to 2021
  16. Characterization of the cagA-gene in Helicobacter pylori in Mongolia and detection of two EPIYA-A enriched CagA types
  17. Prevalence and characterization of antimicrobial resistance among gram-negative bacteria isolated from febrile hospitalized patients in central Ethiopia
  18. Detection of invasive Trichosporon asahii in patient blood by a fungal PCR array
  19. Ocular Syphilis: Experience over 11 Years at a German Ophthalmology Reference Centre
  20. High Acquisition Rate of Gram-Negative Multi-Drug Resistant Organism Colonization During Hospitalization: A Perspective from a High Endemic Setting
  21. High Rate of Multidrug-resistance Among Clinical Isolates of Gram-negative Bacteria in Hospitalized Patients With Febrile Diseases in Central Ethiopia
  22. Elimination of fosfomycin during dialysis with the Genius system in septic patients
  23. Clinical and microbiological characterization of sepsis and evaluation of sepsis scores
  24. Carriage of ESBL-producing Gram-negative bacteria by flies captured in a hospital and its suburban surroundings in Ethiopia
  25. Optimierung der mikrobiellen Diagnostik durch Einführung einer Standard Operating Procedure „Blutkulturen“ in der zentralen Notaufnahme
  26. CTX-M-9 group ESBL-producing Raoultella planticola nosocomial infection: first report from sub-Saharan Africa
  27. High rate of extended-spectrum beta-lactamase-producing gram-negative infections and associated mortality in Ethiopia: a systematic review and meta-analysis
  28. Carriage of ESBL-producing Gram-negative bacteria by houseflies captured in a hospital and its suburban surroundings in Ethiopia
  29. Steroid therapy does not affect the rate of indeterminate results with the T-SPOT.TB interferon gamma release assay
  30. Development and Assessment of a Simulator for in Vivo Confocal Microscopy in Fungal and Acanthamoeba Keratitis
  31. Carriage of ESBL-producing Gram-negative bacteria by houseflies captured in a hospital and its suburban surroundings in Ethiopia
  32. Elimination of glycopeptide antibiotics by cytokine hemoadsorption in patients with septic shock: A study of three cases
  33. Cryptococcal meningoencephalitis in an IgG2-deficient patient with multiple sclerosis on fingolimod therapy for more than five years – case report
  34. Mykotische Keratitis: Klinische Zeichen, Diagnose, Therapie
  35. Mycoplasma pneumoniae infections, 11 countries in Europe and Israel, 2011 to 2016
  36. A proteomics approach for the identification of species-specific immunogenic proteins in the Mycobacterium abscessus complex
  37. Das Deutsche Pilz-Keratitis-Register
  38. Long-Term, Low-Frequency Cluster of a German-Imipenemase-1-Producing Enterobacter hormaechei ssp. steigerwaltii ST89 in a Tertiary Care Hospital in Germany
  39. Prevalence and characterization of azole-resistant Aspergillus fumigatus in patients with cystic fibrosis: a prospective multicentre study in Germany
  40. Lymphnode tuberculosis in a 4-year-old boy with relapsed ganglioneuroblastoma: a case report
  41. In-vitro activity of ceftolozane/tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae isolates recovered from hospitalized patients in Germany
  42. Tintelnotia destructans: Ein neuer Feind vor dem Tore
  43. Infectious risk stratification in multiple sclerosis patients receiving immunotherapy
  44. Animal-assisted therapy at a University Centre for Palliative Medicine – a qualitative content analysis of patient records
  45. Fusarium Keratitis in Germany
  46. Protracted Regional Dissemination of GIM-1-Producing Serratia marcescens in Western Germany
  47. A prospective multicenter evaluation of direct molecular detection of blood stream infection from a clinical perspective
  48. Species Diversity of Environmental GIM-1-Producing Bacteria Collected during a Long-Term Outbreak
  49. A prospective study of two isothermal amplification assays compared with real-time PCR, CCNA and toxigenic culture for the diagnosis of Clostridium difficile infection
  50. TB or not TB? Diagnostic difficulties in HIV-positive versus HIV-negative tuberculosis patients with an immigration background in Germany
  51. Intake of Lactobacillus reuteri Improves Incretin and Insulin Secretion in Glucose-Tolerant Humans: A Proof of Concept
  52. Detection and termination of an extended low-frequency hospital outbreak of GIM-1–producing Pseudomonas aeruginosa ST111 in Germany
  53. Rapid Detection and Immune Characterization of Mycobacterium abscessus Infection in Cystic Fibrosis Patients
  54. Characterization of a Novel Metallo-β-Lactamase Variant, GIM-2, from a Clinical Isolate of Enterobacter cloacae in Germany
  55. Tunneling and Suture of Thoracic Epidural Catheters Decrease the Incidence of Catheter Dislodgement
  56. Epidermal EGFR Controls Cutaneous Host Defense and Prevents Inflammation
  57. Genetic Characterization and Emergence of the Metallo-β-Lactamase GIM-1 in Pseudomonas spp. and Enterobacteriaceae during a Long-Term Outbreak
  58. Implant-associated localized osteitis in murine femur fracture by biofilm forming Staphylococcus aureus : A novel experimental model
  59. An emboligenic pulmonary abscess leading to ischemic stroke and secondary brain abscess
  60. The crystal structure of the CRISPR-associated protein Csn2 from Streptococcus agalactiae
  61. Invasive Aspergillosis in Pediatric Oncology Patients: A Rare Event With Poor Prognosis - Case Analysis to Plan Better Targeted Prophylactic or Therapeutic Measurement
  62. Depletion of neutrophil extracellular traps in vivo results in hypersusceptibility to polymicrobial sepsis in mice
  63. A Case of Relapsing-Remitting Neuroborreliosis? Challenges in the Differential Diagnosis of Recurrent Myelitis
  64. Diagnosis of Sexually Transmitted Diseases
  65. Use of a Commercial PCR-Based Line Blot Method for Identification of Bacterial Pathogens and themecAandvanGenes from BacTAlert Blood Culture Bottles: Table 1
  66. Echinococcus multilocularis: The impact of ionizing radiation on metacestodes
  67. German multicentre survey of the antibiotic susceptibility of Bacteroides fragilis group and Prevotella species isolated from intra-abdominal infections: results from the PRISMA study
  68. Fatal outcome of a disseminated dual infection with drug-resistant Mycoplasma hominis and Ureaplasma parvum originating from a septic arthritis in an immunocompromised patient
  69. A set of novel multiplex Taqman real-time PCRs for the detection of diarrhoeagenic Escherichia coli and its use in determining the prevalence of EPEC and EAEC in a university hospital
  70. Antimicrobial and immunoregulatory effector mechanisms in human endothelial cells. Indoleamine 2,3-dioxygenase versus inducible nitric oxide synthase
  71. Antimicrobial and immunoregulatory properties of human tryptophan 2,3-dioxygenase
  72. Cat Scratch Disease – Heterogeneous in Clinical Presentation: Five Unusual Cases of an Infection Caused by Bartonella henselae
  73. The missing link between indoleamine 2,3-dioxygenase mediated antibacterial and immunoregulatory effects
  74. Antimicrobial and immunoregulatory effects mediated by human lung cells: role of IFN-γ-induced tryptophan degradation
  75. Diagnostic and therapeutic implications of neurological complications following paediatric haematopoietic stem cell transplantation
  76. Diphtheria (D) and Tetanus (T) Antibody Values in Children with Acute Lymphoblastic Leukaemia (ALL) after Treatment According to Co-ALL 05/92
  77. Determination of the Performance of Various Root Canal Disinfection Methods after In Situ Carriage
  78. Role of Indoleamine 2,3-Dioxygenase in Antimicrobial Defence and Immuno-Regulation: Tryptophan Depletion Versus Production of Toxic Kynurenines
  79. TRENDS IN INFECTIONS IN CHILDREN WITH MALIGNANT DISEASE IN 2000: Comparison of Data of 1980/81
  80. Exchange transfusion in a preterm infant with hyperbilirubinemia, staphylococcal scalded skin syndrome (SSSS) and sepsis
  81. Immune reconstitution inflammatory syndrome (IRIS) due to Bacille Calmette Guerin (BCG) in an HIV-positive child
  82. Acute Hemorrhagic Pericarditis in a Child with Pneumonia Due to Chlamydophila pneumoniae
  83. GRA9, a new Toxoplasma gondii dense granule protein associated with the intravacuolar network of tubular membranes
  84. Inhibition of human herpes simplex virus type 2�by interferon ? and tumor necrosis factor ? is mediated by indoleamine 2,3-dioxygenase
  85. Nitric Oxide-Mediated Regulation of Gamma Interferon-Induced Bacteriostasis: Inhibition and Degradation of Human Indoleamine 2,3-Dioxygenase
  86. Blood Culture Sampling Rates at a German Pediatric University Hospital and Incidence of Invasive Pneumococcal Disease
  87. Role of Indoleamine-2,3-Dioxygenase in Alpha/Beta and Gamma Interferon-Mediated Antiviral Effects against Herpes Simplex Virus Infections
  88. Enhancement of antimicrobial effects by glucocorticoids
  89. Ocular infection caused by Mycobacterium kansasii in an AIDS patient
  90. Capreomycin in the Treatment of Atypical Mycobacterial Disease in HIV-Positive Patients
  91. Localization of indoleamine 2,3-dioxygenase in human female reproductive organs and the placenta
  92. The detergent octylglucoside neutralizes lipopolysaccharide in a specific manner
  93. The Immune System, by P. Parham
  94. Inhibition of indoleamine 2,3-dioxygenase in human macrophages inhibits interferon-γ-induced bacteriostasis but does not abrogate toxoplasmastasis
  95. Inducible anti-parasitic effector mechanisms in human uroepithelial cells: tryptophan degradation vs. NO production
  96. Protamine Enhances the Activity of Human Recombinant Interferon-γ
  97. Anti-parasitic effector mechanisms in human brain tumor cells: Role of interferon-γ and tumor necrosis factor-α